Pesquisas alternativas:
peto compared » pet compared (Expandir a Pesquisa), ratio compared (Expandir a Pesquisa), vitro compared (Expandir a Pesquisa)
compared law » compared a (Expandir a Pesquisa), compared _ (Expandir a Pesquisa), company law (Expandir a Pesquisa)
name company » age company (Expandir a Pesquisa), care company (Expandir a Pesquisa), date company (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
company a » company _ (Expandir a Pesquisa)
law note » law notes (Expandir a Pesquisa), law noise (Expandir a Pesquisa)
shi can » shi cai (Expandir a Pesquisa), shi chang (Expandir a Pesquisa), shi chuan (Expandir a Pesquisa)
le shi » le shin (Expandir a Pesquisa), le shu (Expandir a Pesquisa), le sha (Expandir a Pesquisa)
j name » a name (Expandir a Pesquisa), j nare (Expandir a Pesquisa), j nave (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
j le » j l (Expandir a Pesquisa), j e (Expandir a Pesquisa), j de (Expandir a Pesquisa)
peto compared » pet compared (Expandir a Pesquisa), ratio compared (Expandir a Pesquisa), vitro compared (Expandir a Pesquisa)
compared law » compared a (Expandir a Pesquisa), compared _ (Expandir a Pesquisa), company law (Expandir a Pesquisa)
name company » age company (Expandir a Pesquisa), care company (Expandir a Pesquisa), date company (Expandir a Pesquisa)
can newts » can new (Expandir a Pesquisa), can newly (Expandir a Pesquisa)
company a » company _ (Expandir a Pesquisa)
law note » law notes (Expandir a Pesquisa), law noise (Expandir a Pesquisa)
shi can » shi cai (Expandir a Pesquisa), shi chang (Expandir a Pesquisa), shi chuan (Expandir a Pesquisa)
le shi » le shin (Expandir a Pesquisa), le shu (Expandir a Pesquisa), le sha (Expandir a Pesquisa)
j name » a name (Expandir a Pesquisa), j nare (Expandir a Pesquisa), j nave (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
j le » j l (Expandir a Pesquisa), j e (Expandir a Pesquisa), j de (Expandir a Pesquisa)
1
“...Objective: Specific goals were to review systematically the writings of tobacco companies to: (a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“... history and on non-genetic risk factors as diet and physical activity that can have the strongest impact...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Keenan, J, Poland, F, Wilson, P, Mathie, E, Boote, J, Varley, A, Wythe, H, Wellings, A, Vicary, P, Cowe, M, Munday, D, Howe, A
Publicado no BMJ Open (2017)
“..., a clear distinction is made between what ‘involvement’ in research is: ‘research being carried out...”Publicado no BMJ Open (2017)
Obter o texto integral
Obter o texto integral
Artigo
4
“... and results for notifiable disease reporting through ELR (2). Logical Observation Identifiers Names and Codes...”
Obter o texto integral
Obter o texto integral
Artigo
5
Por Foss, Alexander J E, Scott, Lauren J, Rogers, Chris A, Reeves, Barney C, Ghanchi, Faruque, Gibson, Jonathan, Chakravarthy, Usha
Publicado no Br J Ophthalmol (2016)
“... either ranibizumab or bevacizumab and to two regimens, namely monthly (continuous) or as needed...”Publicado no Br J Ophthalmol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Limmroth, V, Reischl, J, Mann, B, Morosov, X, Kokoschka, A, Weller, I, Schreiner, T
Publicado no Patient Prefer Adherence (2017)
“... for the two non-used devices were presented and participants could dummy-inject into a pillow. Last, patients...”Publicado no Patient Prefer Adherence (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Badgeley, Marcus A, Shameer, Khader, Glicksberg, Benjamin S, Tomlinson, Max S, Levin, Matthew A, McCormick, Patrick J, Kasarskis, Andrew, Reich, David L, Dudley, Joel T
Publicado no BMJ Open (2016)
“.... MATERIALS AND METHODS: We developed a clinical dashboard development framework called electronic healthcare...”Publicado no BMJ Open (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Mallory, Emily K., Acharya, Ambika, Rensi, Stefano E., Turnbaugh, Peter J., Bright, Roselie A., Altman, Russ B.
Publicado no Pac Symp Biocomput (2018)
“... has yielded >50 drugs after nearly a century of experimental research. However, there are limited...”Publicado no Pac Symp Biocomput (2018)
Obter o texto integral
Obter o texto integral
Artigo
9
Por Schroeder, Scott R, Salomon, Meghan M, Galanter, William L, Schiff, Gordon D, Vaida, Allen J, Gaunt, Michael J, Bryson, Michelle L, Rash, Christine, Falck, Suzanne, Lambert, Bruce L
Publicado no BMJ Qual Saf (2017)
“...BACKGROUND: Drug name confusion is a common type of medication error and a persistent threat...”Publicado no BMJ Qual Saf (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Mahendran, Rathi, Chua, Shi Min, Lim, Haikel A, Yee, Isaac J, Tan, Joyce Y S, Kua, Ee Heok, Griva, Konstadina
Publicado no BMJ Open (2016)
“... in Asian countries, and the instruments used to measure hope and hopelessness. METHORDS: A comprehensive...”Publicado no BMJ Open (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...A total of 1611 women working in a large electronics company were interviewed using a modified...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... making might be affected by non-medical factors such as third-party reimbursement (e.g., selection...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Tack, J, Camilleri, M, Chang, L, Chey, W D, Galligan, J J, Lacy, B E, Müller-Lissner, S, Quigley, E M M, Schuurkes, J, Maeyer, J H, Stanghellini, V
Publicado em 2012
“... associated with cardiovascular adverse events (AEs). AIM: To perform a systematic review of the safety...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Weersink, Rianne A, Bouma, Margriet, Burger, David M, Drenth, Joost P H, Hunfeld, Nicole G M, Kranenborg, Minke, Monster-Simons, Margje H, van Putten, Sandra A W, Metselaar, Herold J, Taxis, Katja, Borgsteede, Sander D
Publicado no BMJ Open (2016)
“...INTRODUCTION: Liver cirrhosis can have a major impact on drug pharmacokinetics and pharmacodynamics...”Publicado no BMJ Open (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... and stabilization. We have identified a family of 13 proteins in Tetrahymena that contain centrin-binding repeats...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Sittig, Judith S, Uiterwaal, Cuno S P M, Moons, Karel G M, Russel, Ingrid M B, Nievelstein, Rutger A J, Nieuwenhuis, Edward E S, van de Putte, Elise M
Publicado no BMJ Open (2016)
“... additional information, namely, an injury history taken by a paediatrician, information provided...”Publicado no BMJ Open (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por White, Abby, Kucukak, Suden, Bueno, Raphael, Servais, Elliot, Lee, Daniel N., Colson, Yolonda, Jaklitsch, Michael, McNamee, Ciaran, Mentzer, Steven, Wee, Jon, Swanson, Scott J.
Publicado no J Thorac Dis (2017)
“... curves were compared using the log rank test. Significance was defined as a P value less than 0.05...”Publicado no J Thorac Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“... National Health Insurance Law that requires annual reporting of payments from pharmaceutical companies (PCs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Van Campen, Luann E., Allen, Albert J., Watson, Susan B., Therasse, Donald G.
Publicado no AJOB Empir Bioeth (2015)
“... a bioethics consultation service at a pharmaceutical company, to report characteristics...”Publicado no AJOB Empir Bioeth (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Long, Rowena L., Stevens, Jason C., Griffiths, Erin M., Adamek, Markus, Gorecki, Marta J., Powles, Stephen B., Merritt, David J.
Publicado em 2011
“...), and it is not known whether seemingly non-responsive species can be induced to respond. Here a major agronomic weed...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo